Prolonged Exposure to Oxaliplatin during HIPEC Improves Effectiveness in a Preclinical Micrometastasis Model

SIMPLE SUMMARY: Absence of survival benefits when adding hyperthermic intraperitoneal chemotherapy (HIPEC) with oxaliplatin to cytoreductive surgery in peritoneal metastasis from colorectal cancer has recently been shown in the randomized controlled PRODIGE 7 trial. We therefore aimed to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Seyfried, Nick, Yurttas, Can, Burkard, Markus, Oswald, Benedikt, Tolios, Alexander, Herster, Franziska, Kauer, Joseph, Jäger, Tarkan, Königsrainer, Ingmar, Thiel, Karolin, Quante, Markus, Rammensee, Hans-Georg, Venturelli, Sascha, Schwab, Matthias, Königsrainer, Alfred, Beckert, Stefan, Löffler, Markus W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909393/
https://www.ncbi.nlm.nih.gov/pubmed/35267468
http://dx.doi.org/10.3390/cancers14051158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909393/
https://www.ncbi.nlm.nih.gov/pubmed/35267468
http://dx.doi.org/10.3390/cancers14051158

Ejemplares similares